{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:41:13Z","timestamp":1773294073435,"version":"3.50.1"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.bbi.2022.07.163","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T01:14:49Z","timestamp":1659143689000},"page":"89-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Clenbuterol attenuates immune reaction to lipopolysaccharide and its relationship to anhedonia in adolescents"],"prefix":"10.1016","volume":"106","author":[{"given":"Tram N.B.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin A.","family":"Ely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Pick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manishkumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seunghee","family":"Kim-Schulze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vilma","family":"Gabbay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2022.07.163_b0005","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbi.2018.09.004","article-title":"The beta2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion","volume":"74","author":"Agac","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2022.07.163_b0010","unstructured":"American Psychiatric Association, A., Diagnostic and statistical manual of mental disorders (DSM-IV). 1994."},{"key":"10.1016\/j.bbi.2022.07.163_b0015","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, A., Diagnostic and statistical manual of mental disorders (DSM-5\u00ae). 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.bbi.2022.07.163_b0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fncel.2013.00068","article-title":"Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses","volume":"7","author":"Audet","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbi.2022.07.163_b0025","doi-asserted-by":"crossref","first-page":"9130868","DOI":"10.1155\/2019\/9130868","article-title":"Alterations in the levels of growth factors in adolescents with major depressive disorder: A longitudinal study during the treatment with fluoxetine","volume":"2019","author":"Becerril-Villanueva","year":"2019","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bbi.2022.07.163_b0030","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2022.07.163_b0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0006-8993(88)91453-9","article-title":"Regionally selective increases in \u03b2-adrenergic receptor density in the brains of suicide victims","volume":"442","author":"Biegon","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2022.07.163_b0040","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbi.2019.04.014","article-title":"Relationships between neural activation during a reward task and peripheral cytokine levels in youth with diverse psychiatric symptoms","volume":"80","author":"Bradley","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.bbi.2022.07.163_b0045","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cyto.2014.10.030","article-title":"Bead-based multiplex immuno-assays for cytokines, chemokines, growth factors and other analytes: median fluorescence intensities versus their derived absolute concentration values for statistical analysis","volume":"71","author":"Breen","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.bbi.2022.07.163_b0050","doi-asserted-by":"crossref","first-page":"26996","DOI":"10.1038\/srep26996","article-title":"The statistical value of raw fluorescence signal in luminex xmap based multiplex immunoassays","volume":"6","author":"Breen","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbi.2022.07.163_b0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/0004867416652736","article-title":"Inflammatory cytokines in major depressive disorder: A case-control study","volume":"51","author":"Cassano","year":"2017","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2022.07.163_b0060","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41398-021-01668-1","article-title":"Peripheral immune cell reactivity and neural response to reward in patients with depression and anhedonia","volume":"11","author":"Costi","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2022.07.163_b0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(99)00452-5","article-title":"Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage","volume":"379","author":"Culmsee","year":"1999","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbi.2022.07.163_b0070","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1089\/cap.2019.0015","article-title":"Inflammatory cytokines in children and adolescents with depressive disorders: A systematic review and meta-analysis","volume":"29","author":"D'Acunto","year":"2019","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.bbi.2022.07.163_b0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psyneuen.2014.03.019","article-title":"The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery","volume":"45","author":"Dahl","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2022.07.163_b0080","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1749-6632.2001.tb05827.x","article-title":"Cytokine-induced sickness behavior: mechanisms and implications","volume":"933","author":"Dantzer","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bbi.2022.07.163_b0085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.bbi.2022.07.163_b0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2006.09.006","article-title":"Twenty years of research on cytokine-induced sickness behavior","volume":"21","author":"Dantzer","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2022.07.163_b0095","doi-asserted-by":"crossref","unstructured":"De La Garza, R., 2nd, Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia. Neurosci Biobehav Rev, 2005. 29(4-5): p. 761-70.","DOI":"10.1016\/j.neubiorev.2005.03.016"},{"issue":"1","key":"10.1016\/j.bbi.2022.07.163_b0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0006-8993(90)91321-7","article-title":"Brain beta-adrenoceptor binding sites in antidepressant-free depressed suicide victims","volume":"525","author":"De Paermentier","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2022.07.163_b0105","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jad.2017.11.040","article-title":"A pilot resting-state functional connectivity study of the kynurenine pathway in adolescents with depression and healthy controls","volume":"227","author":"DeWitt","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.bbi.2022.07.163_b0110","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/hipo.20904","article-title":"Seeing old friends from a different angle: novel properties of hematopoietic growth factors in the healthy and diseased brain","volume":"22","author":"Diederich","year":"2012","journal-title":"Hippocampus"},{"key":"10.1016\/j.bbi.2022.07.163_b0115","doi-asserted-by":"crossref","unstructured":"dupont, N.C., et al., Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol, 2005. 66(2): p. 175-91.","DOI":"10.1016\/j.jri.2005.03.005"},{"key":"10.1016\/j.bbi.2022.07.163_b0120","doi-asserted-by":"crossref","unstructured":"Efron, B. and R.J. Tibshirani, An introduction to the bootstrap. 1994: CRC press.","DOI":"10.1201\/9780429246593"},{"key":"10.1016\/j.bbi.2022.07.163_b0125","series-title":"Cambridge","first-page":"173","author":"Ellis","year":"2010"},{"issue":"4","key":"10.1016\/j.bbi.2022.07.163_b0130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ymeth.2005.11.010","article-title":"Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA","volume":"38","author":"Elshal","year":"2006","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.bbi.2022.07.163_b0135","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41398-021-01321-x","article-title":"Data-driven parcellation and graph theory analyses to study adolescent mood and anxiety symptoms","volume":"11","author":"Ely","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"1136","key":"10.1016\/j.bbi.2022.07.163_b0140","article-title":"Multimodal investigations of reward circuitry and anhedonia in adolescent depression","volume":"12","author":"Ely","year":"2021","journal-title":"Frontiers Psychiatry"},{"issue":"9","key":"10.1016\/j.bbi.2022.07.163_b0145","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1080\/15622975.2018.1482000","article-title":"Anhedonia as a clinical correlate of inflammation in adolescents across psychiatric conditions","volume":"20","author":"Freed","year":"2019","journal-title":"World J Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2022.07.163_b0150","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1037\/a0024338","article-title":"Effect size estimates: current use, calculations, and interpretation","volume":"141","author":"Fritz","year":"2012","journal-title":"J. Exp. Psychol. Gen."},{"issue":"6","key":"10.1016\/j.bbi.2022.07.163_b0155","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.pnpbp.2009.05.001","article-title":"A cytokine study in children and adolescents with Tourette's disorder","volume":"33","author":"Gabbay","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.bbi.2022.07.163_b0160","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jad.2008.07.022","article-title":"Immune system dysregulation in adolescent major depressive disorder","volume":"115","author":"Gabbay","year":"2009","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.bbi.2022.07.163_b0165","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/cap.2008.0140","article-title":"A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression","volume":"19","author":"Gabbay","year":"2009","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2022.07.163_b0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pnpbp.2009.09.015","article-title":"The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study","volume":"34","author":"Gabbay","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2022.07.163_b0175","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00702-011-0685-7","article-title":"The possible role of the kynurenine pathway in anhedonia in adolescents","volume":"119","author":"Gabbay","year":"2012","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"6","key":"10.1016\/j.bbi.2022.07.163_b0180","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jrp.2005.11.001","article-title":"Anticipatory and consummatory components of the experience of pleasure: a scale development study","volume":"40","author":"Gard","year":"2006","journal-title":"J. Res. Pers."},{"key":"10.1016\/j.bbi.2022.07.163_b0185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eurpsy.2016.05.012","article-title":"Assessing social anhedonia in adolescence: The ACIPS-A in a community sample","volume":"37","author":"Gooding","year":"2016","journal-title":"Eur Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2022.07.163_b0190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.biopsych.2009.02.029","article-title":"Reward processing after catecholamine depletion in unmedicated, remitted subjects with major depressive disorder","volume":"66","author":"Hasler","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2022.07.163_b0195","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fpsyt.2019.00030","article-title":"Cytokine research in depression: principles, challenges, and open questions","volume":"10","author":"Himmerich","year":"2019","journal-title":"Front. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2022.07.163_b0200","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/00223891.2014.940625","article-title":"Factor structure and construct validity of the temporal experience of pleasure scales","volume":"97","author":"Ho","year":"2015","journal-title":"J. Pers. Assess."},{"issue":"5","key":"10.1016\/j.bbi.2022.07.163_b0205","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/da.20564","article-title":"Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder","volume":"26","author":"Hoge","year":"2009","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.bbi.2022.07.163_b0210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jpsychires.2020.12.051","article-title":"Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorder","volume":"134","author":"Idemoto","year":"2021","journal-title":"J. Psychiatr. Res."},{"issue":"7","key":"10.1016\/j.bbi.2022.07.163_b0215","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","article-title":"Research domain criteria (RDoC): toward a new classification framework for research on mental disorders","volume":"167","author":"Insel","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2022.07.163_b0220","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/00001756-199703240-00031","article-title":"Expression and distribution of CC chemokine macrophage inflammatory protein-1 alpha\/LD78 in the human brain","volume":"8","author":"Ishizuka","year":"1997","journal-title":"NeuroReport"},{"issue":"9","key":"10.1016\/j.bbi.2022.07.163_b0225","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s000110050493","article-title":"The beta-adrenoceptor agonist clenbuterol is a potent inhibitor of the LPS-induced production of TNF-alpha and IL-6 in vitro and in vivo","volume":"48","author":"Izeboud","year":"1999","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.bbi.2022.07.163_b0230","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/cei.12396","article-title":"Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection","volume":"178","author":"Jenabian","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.bbi.2022.07.163_b0235","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jclp.20591","article-title":"Loving-kindness meditation to enhance recovery from negative symptoms of schizophrenia","volume":"65","author":"Johnson","year":"2009","journal-title":"J. Clin. Psychol."},{"issue":"1","key":"10.1016\/j.bbi.2022.07.163_b0240","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cyto.2013.02.007","article-title":"IL-1 and EGF regulate expression of genes important in inflammation and cancer","volume":"62","author":"Kasza","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.bbi.2022.07.163_b0245","series-title":"Manual for the Kaufman brief intelligence test","author":"Kaufman","year":"1990"},{"issue":"7","key":"10.1016\/j.bbi.2022.07.163_b0250","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","article-title":"Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data","volume":"36","author":"Kaufman","year":"1997","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2022.07.163_b0255","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0031-6997(24)01510-2","article-title":"Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo","volume":"53","author":"Kohm","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbi.2022.07.163_b0260","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bbi.2014.10.007","article-title":"beta2-Adrenergic receptors in immunity and inflammation: stressing NF-kappaB","volume":"45","author":"Kolmus","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.bbi.2022.07.163_b0265","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0166-2236(00)02088-9","article-title":"Cytokine-induced sickness behaviour: mechanisms and implications","volume":"25","author":"Konsman","year":"2002","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.bbi.2022.07.163_b0270","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12974-019-1506-4","article-title":"Augmented beta2-adrenergic signaling dampens the neuroinflammatory response following ischemic stroke and increases stroke size","volume":"16","author":"Lechtenberg","year":"2019","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.bbi.2022.07.163_b0275","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbi.2020.04.063","article-title":"Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I\/II depression","volume":"88","author":"Lee","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2022.07.163_b0280","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev.bi.52.070183.001111","article-title":"Adenylate cyclase-coupled beta-adrenergic receptors: structure and mechanisms of activation and desensitization","volume":"52","author":"Lefkowitz","year":"1983","journal-title":"Annu. Rev. Biochem."},{"issue":"2","key":"10.1016\/j.bbi.2022.07.163_b0285","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.psyneuen.2009.06.007","article-title":"Serum chemokine levels in major depressive disorder","volume":"35","author":"Lehto","year":"2010","journal-title":"Psychoneuroendocrinology"},{"issue":"8","key":"10.1016\/j.bbi.2022.07.163_b0290","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/gerona\/63.8.879","article-title":"ELISA and multiplex technologies for cytokine measurement in inflammation and aging research","volume":"63","author":"Leng","year":"2008","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"11","key":"10.1016\/j.bbi.2022.07.163_b0295","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.4088\/JCP.v67n1114","article-title":"Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy","volume":"67","author":"Leo","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2022.07.163_b0300","doi-asserted-by":"crossref","first-page":"860","DOI":"10.5993\/AJHB.36.6.12","article-title":"Relations between anhedonia and physical activity","volume":"36","author":"Leventhal","year":"2012","journal-title":"Am J Health Behav"},{"key":"10.1016\/j.bbi.2022.07.163_b0305","doi-asserted-by":"crossref","unstructured":"Li, C.Y., et al., Adrenaline inhibits lipopolysaccharide-induced macrophage inflammatory protein-1 alpha in human monocytes: the role of beta-adrenergic receptors. Anesth Analg, 2003. 96(2): p. 518-23, table of contents.","DOI":"10.1213\/00000539-200302000-00040"},{"key":"10.1016\/j.bbi.2022.07.163_b0310","article-title":"Correlates of C-reactive protein with neural reward circuitry in adolescents with psychiatric symptoms. Brain Behav Immun","volume":"9","author":"Liu","year":"2020","journal-title":"Health"},{"issue":"4","key":"10.1016\/j.bbi.2022.07.163_b0315","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00004583-199704000-00019","article-title":"The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity","volume":"36","author":"March","year":"1997","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2022.07.163_b0320","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbi.2010.02.005","article-title":"Noradrenaline acting at central beta-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration","volume":"24","author":"McNamee","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2022.07.163_b0325","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.psychres.2017.05.012","article-title":"Role of IL-8, CRP and epidermal growth factor in depression and anxiety patients treated with mindfulness-based therapy or cognitive behavioral therapy in primary health care","volume":"254","author":"Memon","year":"2017","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.bbi.2022.07.163_b0330","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1359-6101(02)00045-X","article-title":"Macrophage inflammatory protein-1","volume":"13","author":"Menten","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.bbi.2022.07.163_b0335","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2005.11.006","article-title":"Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application","volume":"110","author":"Millan","year":"2006","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.bbi.2022.07.163_b0340","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/da.22084","article-title":"Cytokine targets in the brain: impact on neurotransmitters and neurocircuits","volume":"30","author":"Miller","year":"2013","journal-title":"Depress Anxiety"},{"issue":"9","key":"10.1016\/j.bbi.2022.07.163_b0345","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2022.07.163_b0350","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jaac.2013.11.013","article-title":"Inflammation in children and adolescents with neuropsychiatric disorders: a systematic review","volume":"53","author":"Mitchell","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2022.07.163_b0355","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.imlet.2005.05.008","article-title":"Beta2-adrenergic receptor stimulation inhibits LPS-induced IL-18 and IL-12 production in monocytes","volume":"101","author":"Mizuno","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bbi.2022.07.163_b0360","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbi.2022.07.163_b0365","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.neubiorev.2019.08.015","article-title":"Hierarchical control systems for the regulation of physiological homeostasis and affect: Can their interactions modulate mood and anhedonia?","volume":"105","author":"Muzik","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2022.07.163_b0370","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1742-2094-10-43","article-title":"Neuroinflammation and psychiatric illness","volume":"10","author":"Najjar","year":"2013","journal-title":"J Neuroinflammation"},{"issue":"6","key":"10.1016\/j.bbi.2022.07.163_b0375","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/jcpp.12187","article-title":"Annual research review: The neuroinflammation hypothesis for stress and psychopathology in children\u2013developmental psychoneuroimmunology","volume":"55","author":"O'Connor","year":"2014","journal-title":"J. Child Psychol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2022.07.163_b0380","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.pharep.2018.06.001","article-title":"The association between inflammatory markers (iNOS, HO-1, IL-33, MIP-1beta) and depression with and without posttraumatic stress disorder","volume":"70","author":"Oglodek","year":"2018","journal-title":"Pharmacol. Rep."},{"issue":"4","key":"10.1016\/j.bbi.2022.07.163_b0385","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1378\/chest.117.4.1162","article-title":"Anti-inflammatory cytokines","volume":"117","author":"Opal","year":"2000","journal-title":"Chest"},{"issue":"49","key":"10.1016\/j.bbi.2022.07.163_b0390","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","article-title":"Activators and target genes of Rel\/NF-kappaB transcription factors","volume":"18","author":"Pahl","year":"1999","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bbi.2022.07.163_b0395","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jlb.55.3.313","article-title":"Beta 2-adrenoceptor agonists regulate the IL-4-induced phenotypical changes and IgE-dependent functions in normal human monocytes","volume":"55","author":"Paul-Eugene","year":"1994","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.bbi.2022.07.163_b0400","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2022.07.163_b0405","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/1087057110362099","article-title":"Quantitative validation and comparison of multiplex cytokine kits","volume":"15","author":"Richens","year":"2010","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.bbi.2022.07.163_b0410","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev.psych.52.1.59","article-title":"Meta-analysis: recent developments in quantitative methods for literature reviews","volume":"52","author":"Rosenthal","year":"2001","journal-title":"Annu. Rev. Psychol."},{"issue":"5","key":"10.1016\/j.bbi.2022.07.163_b0415","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1615\/CritRevImmunol.v31.i5.20","article-title":"LPS-induced cytokine production in human monocytes and macrophages","volume":"31","author":"Rossol","year":"2011","journal-title":"Crit. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.bbi.2022.07.163_b0420","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.neuint.2013.07.006","article-title":"Stimulation of central beta2-adrenoceptors suppresses NFkappaB activity in rat brain: a role for IkappaB","volume":"63","author":"Ryan","year":"2013","journal-title":"Neurochem. Int."},{"issue":"2","key":"10.1016\/j.bbi.2022.07.163_b0425","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbi.2011.08.001","article-title":"The beta2-adrenergic receptor on T and B lymphocytes: do we understand it yet?","volume":"26","author":"Sanders","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2022.07.163_b0430","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fphar.2015.00171","article-title":"Adrenergic regulation of innate immunity: a review","volume":"6","author":"Scanzano","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2022.07.163_b0435","doi-asserted-by":"crossref","first-page":"e22546","DOI":"10.4161\/onci.22546","article-title":"The role of soluble CD40L in immunosuppression","volume":"2","author":"Schlom","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbi.2022.07.163_b0440","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jad.2016.02.067","article-title":"Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies","volume":"197","author":"Sharma","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.bbi.2022.07.163_b0445","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/0269881115612236","article-title":"Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis","volume":"30","author":"Steenen","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2022.07.163_b0450","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4049\/jimmunol.166.1.232","article-title":"IFN-gamma production by Th1 cells generated from naive CD4+ T cells exposed to norepinephrine","volume":"166","author":"Swanson","year":"2001","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.bbi.2022.07.163_b0455","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1124\/jpet.102.042622","article-title":"Effect of beta 2-adrenergic receptor stimulation on interleukin-18-induced intercellular adhesion molecule-1 expression and cytokine production","volume":"304","author":"Takahashi","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3\u20134","key":"10.1016\/j.bbi.2022.07.163_b0460","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/prca.201400130","article-title":"ELISA in the multiplex era: potentials and pitfalls","volume":"9","author":"Tighe","year":"2015","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.bbi.2022.07.163_b0465","unstructured":"Tomczak, M. and E. Tomczak, The need to report effect size estimates revisited. An overview of some recommended measures of effect size. 2014."},{"key":"10.1016\/j.bbi.2022.07.163_b0470","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jad.2016.08.058","article-title":"Exercise is an effective treatment for positive valence symptoms in major depression","volume":"209","author":"Toups","year":"2017","journal-title":"J. Affect. Disord."},{"issue":"8","key":"10.1016\/j.bbi.2022.07.163_b0475","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s11259-006-3383-4","article-title":"Clenbuterol affects the expression of messenger RNA for interleukin 10 in peripheral leukocytes from horses challenged intrabronchially with lipopolysaccharides","volume":"30","author":"van den Hoven","year":"2006","journal-title":"Vet. Res. Commun."},{"issue":"7","key":"10.1016\/j.bbi.2022.07.163_b0480","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/archgenpsychiatry.2009.64","article-title":"Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder","volume":"66","author":"Van Snellenberg","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2022.07.163_b0485","unstructured":"Van Snellenberg, J.X. BCa_bootstrap. 2018 15 Oct 2018 [cited 2021 April 25]; Available from: https:\/\/www.mathworks.com\/matlabcentral\/fileexchange\/69119."},{"issue":"3","key":"10.1016\/j.bbi.2022.07.163_b0490","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1055\/s-2007-1014446","article-title":"The action of clenbuterol on sleep and symptomatology in depressives","volume":"24","author":"Wiegand","year":"1991","journal-title":"Pharmacopsychiatry"},{"issue":"35","key":"10.1016\/j.bbi.2022.07.163_b0495","doi-asserted-by":"crossref","first-page":"31027","DOI":"10.1074\/jbc.M501473200","article-title":"The platelet-derived growth factor receptor-beta phosphorylates and activates G protein-coupled receptor kinase-2. A mechanism for feedback inhibition","volume":"280","author":"Wu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2022.07.163_b0500","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3389\/fphar.2018.01313","article-title":"Bidirectional Role of beta2-Adrenergic Receptor in Autoimmune Diseases","volume":"9","author":"Wu","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbi.2022.07.163_b0505","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000139481","article-title":"Inhibition of tumor necrosis factor-alpha and interleukin-1-beta production by beta-adrenoceptor agonists from lipopolysaccharide-stimulated human peripheral blood mononuclear cells","volume":"54","author":"Yoshimura","year":"1997","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.bbi.2022.07.163_b0510","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00213-003-1512-0","article-title":"Antagonism of the antidepressant-like effects of clenbuterol by central administration of beta-adrenergic antagonists in rats","volume":"170","author":"Zhang","year":"2003","journal-title":"Psychopharmacology"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159122003373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159122003373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:18:16Z","timestamp":1760170696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159122003373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":102,"alternative-id":["S0889159122003373"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2022.07.163","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.07.455522","asserted-by":"object"}]},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clenbuterol attenuates immune reaction to lipopolysaccharide and its relationship to anhedonia in adolescents","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2022.07.163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}